Haptocorrin as marker of disease progression in fibrolamellar hepatocellular carcinoma
Research output: Contribution to journal › Journal article › Research › peer-review
No valid markers are routinely available to follow disease progression in patients with fibrolamellar hepatocellular carcinoma (FLHCC). We report data suggesting that the vitamin B12 binding protein haptocorrin (HC) may prove a suitable marker.
| Original language | English |
|---|---|
| Journal | European Journal of Surgical Oncology |
| Volume | 37 |
| Issue number | 1 |
| Pages (from-to) | 72-79 |
| Number of pages | 8 |
| ISSN | 0748-7983 |
| DOIs | |
| Publication status | Published - 1 Jan 2011 |
- Adolescent, Carcinoma, Hepatocellular, Disease Progression, Humans, Liver Neoplasms, Male, Tomography, X-Ray Computed, Transcobalamins, Tumor Markers, Biological
Research areas
ID: 33792447